Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

In Vivo Treatment with TG-02 Results in Increased Mobilization and Sensitization of Leukemia Stem Cells to Chemotherapeutic Agents

Zeena Salman, MD MPH, Jeanne P. De Leon, Eric J. Feldman, MD, Francis Burrows, PhD, Gail J. Roboz, MD, Monica L. Guzman, PhD

Blood (2014) 124 (21): 3765.

https://doi.org/10.1182/blood.V124.21.3765.3765

Published: 2014

Journal Articles

Leukemia Stem/Progenitor Cells From AML Patients Treated With The Multi-Kinase Inhibitor TG02 Demonstrate Increased Proliferation and Are Sensitized To Chemotherapeutic Agents

Monica L. Guzman, PhD, Wen Xie, MS, Jeanne P. De Leon, Francis Burrows, PhD, Eric J. Feldman, MD, Gail J. Roboz, MD

Blood (2013) 122 (21): 3892.

https://doi.org/10.1182/blood.V122.21.3892.3892

Published: 2013

Journal Articles

FLT3-ITD+ AML Blast, Progenitor and Stem Cell Populations Demonstrate Higher Sensitivity to the Hsp90 Inhibitor PU-H71,

Hongliang Zong, MD, PhD, Tony Taldone, PhD, James H. Ahn, Sarah Brennan, PhD, Jeanne P. De Leon, Michael W. Becker, MD, Gail J. Roboz, MD, Gabriela Chiosis, PhD, Monica L. Guzman, PhD

Blood (2011) 118 (21): 3500.

https://doi.org/10.1182/blood.V118.21.3500.3500

Published: 2011

Journal Articles

Investigational NEDD8-Activating Enzyme (NAE) Inhibitor, MLN4924, Demonstrates Activity Against Primary AML Blast, Progenitor and Stem Cell Populations

Siddhartha Sen, PhD, Jeanne P. De Leon, Peter G Smith, PhD, Gail J. Roboz, MD, Monica L. Guzman, PhD

Blood (2011) 118 (21): 1414.

https://doi.org/10.1182/blood.V118.21.1414.1414

Published: 2011

Journal Articles

Troglitazone and Prochloroperazine Repositioned As An Anti-Leukemia Stem Cell Drug Combination Using Chemical Genomics-Based Prediction

Duane C Hassane, PhD, Jeanne P. De Leon, Cheryl Corbett, Randall M Rossi, MS, Wen Xie, MS, Craig T. Jordan, PhD, Monica L. Guzman, PhD

Blood (2011) 118 (21): 1885.

https://doi.org/10.1182/blood.V118.21.1885.1885

Published: 2011

NARROW

In Vivo Treatment with TG-02 Results in Increased Mobilization and Sensitization of Leukemia Stem Cells to Chemotherapeutic Agents

Leukemia Stem/Progenitor Cells From AML Patients Treated With The Multi-Kinase Inhibitor TG02 Demonstrate Increased Proliferation and Are Sensitized To Chemotherapeutic Agents

FLT3-ITD+ AML Blast, Progenitor and Stem Cell Populations Demonstrate Higher Sensitivity to the Hsp90 Inhibitor PU-H71,

Investigational NEDD8-Activating Enzyme (NAE) Inhibitor, MLN4924, Demonstrates Activity Against Primary AML Blast, Progenitor and Stem Cell Populations

Troglitazone and Prochloroperazine Repositioned As An Anti-Leukemia Stem Cell Drug Combination Using Chemical Genomics-Based Prediction

Email alerts

ASH Publications

American Society of Hematology

In Vivo Treatment with TG-02 Results in Increased Mobilization and Sensitization of Leukemia Stem Cells to Chemotherapeutic Agents

Leukemia Stem/Progenitor Cells From AML Patients Treated With The Multi-Kinase Inhibitor TG02 Demonstrate Increased Proliferation and Are Sensitized To Chemotherapeutic Agents

FLT3-ITD+ AML Blast, Progenitor and Stem Cell Populations Demonstrate Higher Sensitivity to the Hsp90 Inhibitor PU-H71,

Investigational NEDD8-Activating Enzyme (NAE) Inhibitor, MLN4924, Demonstrates Activity Against Primary AML Blast, Progenitor and Stem Cell Populations

Troglitazone and Prochloroperazine Repositioned As An Anti-Leukemia Stem Cell Drug Combination Using Chemical Genomics-Based Prediction

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only